Intra‑tumoral treatment with oxygen‑ozone in glioblastoma: A systematic literature search and results of a case series

Megele,Richard; Riemenschneider,Markus  J.; Dodoo‑Schittko,Frank; Feyrer,Matthias; Kleindienst,Andrea

doi:10.3892/ol.2018.9397

Intra‑tumoral treatment with oxygen‑ozone in glioblastoma: A systematic literature search and results of a case series

Authors:
- Richard Megele
- Markus J. Riemenschneider
- Frank Dodoo‑Schittko
- Matthias Feyrer
- Andrea Kleindienst
View Affiliations

Affiliations: Department of Neurosurgery, Klinikum St. Marien, D‑92224 Amberg, Germany, Department of Neuropathology, Regensburg University Hospital, D‑93053 Regensburg, Germany, Medical Sociology, Institute of Epidemiology and Preventative Medicine, University of Regensburg, D‑93053 Regensburg, Germany, Department of Radiology, Klinikum St. Marien, D‑92224 Amberg, Germany
Published online on: September 5, 2018 https://doi.org/10.3892/ol.2018.9397
Pages: 5813-5822
Copyright: © Megele et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Despite progress in surgery and radiochemotherapy, the prognosis of glioblastoma (GB) remains poor. GB cells exhibit a preference for hypoxia to maintain their tumor‑forming capacity. Treatment strategies utilizing oxygen (O2) or ozone (O3) and generating reactive oxygen species induce cell growth inhibition and apoptosis. The anti‑tumorigenic properties of O2‑O3 are accompanied by a key role in regulating immunogenicity. The present study reported a case series of an intra‑tumoral O2‑O3 application in recurrent GB. Following surgery in combination with standard radiochemotherapy, O2‑O3 (5 ml at 40 µg/ml) was applied every four weeks into the tumor vicinity. The patients received a median of 27 (range, 3‑44) O2‑O3 applications. In addition, a systematic literature search was performed in order to evaluate the role of O3 in the treatment of malignancies. The median overall survival rate was 40 (range, 16‑53) months. The median survival rate following the first recurrence or the initiation of the O2‑O3 treatment, respectively, was 34 (range, 12‑53) months. In one patient, a local infection and in another, hemorrhage occurred, necessitating in both the temporary removal of the reservoir. The data from the present study support the potential benefit of an intra‑tumoral O2‑O3 application in recurrent GB. The scientific literature revealed by the bibliographic search suggests that O3 may be considered a viable adjuvant therapy in oncological patients. The present study may serve as a starting point for further observational and clinical studies elucidating the cellular and systemic effects of O2 and/or O3 and demonstrating their efficacy and safety in larger patient samples.

View Figures

View References

1	Park JK, Hodges T, Arko L, Shen M, Iacono Dello D, McNabb A, Bailey Olsen N, Kreisl TN, Iwamoto FM, Sul J, et al: Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol. 28:3838–3843. 2010. View Article : Google Scholar : PubMed/NCBI
2	Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
3	Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, et al: Long-term survival with glioblastoma multiforme. Brain. 130:2596–2606. 2007. View Article : Google Scholar : PubMed/NCBI
4	Ringel F, Pape H, Sabel M, Krex D, Bock HC, Misch M, Weyerbrock A, Westermaier T, Senft C, Schucht P, et al: Clinical benefit from resection of recurrent glioblastomas: Results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection. Neuro Oncol. 18:96–104. 2016. View Article : Google Scholar : PubMed/NCBI
5	Kathagen A, Schulte A, Balcke G, Phillips HS, Martens T, Matschke J, Günther HS, Soriano R, Modrusan Z, Sandmann T, et al: Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells. Acta Neuropathol. 126:763–780. 2013. View Article : Google Scholar : PubMed/NCBI
6	Seidel S, Garvalov BK, Wirta V, von Stechow L, Schänzer A, Meletis K, Wolter M, Sommerlad D, Henze AT, Nistér M, et al: A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain. 133:983–995. 2010. View Article : Google Scholar : PubMed/NCBI
7	Zhou Y, Zhou Y, Shingu T, Feng L, Chen Z, Ogasawara M, Keating MJ, Kondo S and Huang P: Metabolic alterations in highly tumorigenic glioblastoma cells: Preference for hypoxia and high dependency on glycolysis. J Biol Chem. 286:32843–32853. 2011. View Article : Google Scholar : PubMed/NCBI
8	Bar EE, Lin A, Mahairaki V, Matsui W and Eberhart CG: Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol. 177:1491–1502. 2010. View Article : Google Scholar : PubMed/NCBI
9	Eckerich C, Zapf S, Fillbrandt R, Loges S, Westphal M and Lamszus K: Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration. Int J Cancer. 121:276–283. 2007. View Article : Google Scholar : PubMed/NCBI
10	Trejo-Solis C, Jimenez-Farfan D, Rodriguez-Enriquez S, Fernandez-Valverde F, Cruz-Salgado A, Ruiz-Azuara L and Sotelo J: Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and JNK activation. BMC Cancer. 12:1562012. View Article : Google Scholar : PubMed/NCBI
11	Mendichovszky I and Jackson A: Imaging hypoxia in gliomas. Br J Radiol. 84:S145–S158. 2011. View Article : Google Scholar : PubMed/NCBI
12	Kadayakkara DK, Janjic JM, Pusateri LK, Young WB and Ahrens ET: In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn Reson Med. 64:1252–1259. 2010. View Article : Google Scholar : PubMed/NCBI
13	Olin MR, Andersen BM, Litterman AJ, Grogan PT, Sarver AL, Robertson PT, Liang X, Chen W, Parney IF, Hunt MA, et al: Oxygen is a master regulator of the immunogenicity of primary human glioma cells. Cancer Res. 71:6583–6589. 2011. View Article : Google Scholar : PubMed/NCBI
14	Cannizzaro A, Falzacappa Verga CV, Martinelli M, Misiti S, Brunetti E and Bucci B: O(2/3) exposure inhibits cell progression affecting cyclin B1/cdk1 activity in SK-N-SH while induces apoptosis in SK-N-DZ neuroblastoma cells. J Cell Physiol. 213:115–125. 2007. View Article : Google Scholar : PubMed/NCBI
15	Bocci VA: Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 37:425–435. 2006. View Article : Google Scholar : PubMed/NCBI
16	Batinjan G, Zore Filipovic I, Vuletic M and Rupic I: The use of ozone in the prevention of osteoradionecrosis of the jaw. Saudi Med J. 35:1260–1263. 2014.PubMed/NCBI
17	Brozoski MA, Lemos CA, Da Graca Naclério-Homem M and Deboni MC: Adjuvant aqueous ozone in the treatment of bisphosphonate induced necrosis of the jaws: report of two cases and long-term follow-up. Minerva Stomatol. 63:35–41. 2014.PubMed/NCBI
18	Clavo B, Ceballos D, Gutierrez D, Rovira G, Suarez G, Lopez L, Pinar B, Cabezon A, Morales V, Oliva E, et al: Long-term control of refractory hemorrhagic radiation proctitis with ozone therapy. J Pain Symptom Manage. 46:106–112. 2013. View Article : Google Scholar : PubMed/NCBI
19	Clavo B, Gutiérrez D, Martín D, Suárez G, Hernández MA and Robaina F: Intravesical ozone therapy for progressive radiation-induced hematuria. J Altern Complement Med. 11:539–541. 2005. View Article : Google Scholar : PubMed/NCBI
20	Ripamonti CI, Cislaghi E, Mariani L and Maniezzo M: Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I–II study. Oral Oncol. 47:185–190. 2011. View Article : Google Scholar : PubMed/NCBI
21	Ripamonti CI, Maniezzo M, Boldini S, Pessi MA, Mariani L and Cislaghi E: Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates-Preliminary data: Medical ozone gas insufflation in treating ONJ lesions. J Bone Oncol. 1:81–87. 2012. View Article : Google Scholar : PubMed/NCBI
22	Petrucci MT, Gallucci C, Agrillo A, Mustazza MC and Foà R: Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica. 92:1289–1290. 2007. View Article : Google Scholar : PubMed/NCBI
23	Herbert RA, Hailey JR, Grumbein S, Chou BJ, Sills RC, Haseman JK, Goehl T, Miller RA, Roycroft JH and Boorman GA: Two-year and lifetime toxicity and carcinogenicity studies of ozone in B6C3F1 mice. Toxicol Pathol. 24:539–548. 1996. View Article : Google Scholar : PubMed/NCBI
24	Ichinose T and Sagai M: Combined exposure to NO2, O3 and H2SO4-aerosol and lung tumor formation in rats. Toxicology. 74:173–184. 1992. View Article : Google Scholar : PubMed/NCBI
25	Donaldson K, Brown GM, Brown DM, Slight J, Maclaren WM and Davis JM: Leukocyte-mediated epithelial injury in ozone-exposed rat lung. Res Rep Health Eff Inst. 1–27. 1991.PubMed/NCBI
26	Hoogervorst EM, de Vries A, Beems RB, van Oostrom CT, Wester PW, Vos JG, Bruins W, Roodbergen M, Cassee FR, Vijg J, et al: Combined oral benzo[a]pyrene and inhalatory ozone exposure have no effect on lung tumor development in DNA repair-deficient Xpa mice. Carcinogenesis. 24:613–619. 2003. View Article : Google Scholar : PubMed/NCBI
27	Witschi H, Wilson DW and Plopper CG: Modulation of N-nitrosodiethylamine-induced hamster lung tumors by ozone. Toxicology. 77:193–202. 1993. View Article : Google Scholar : PubMed/NCBI
28	Last JA, Warren DL, Pecquet-Goad E and Witschi H: Modification by ozone of lung tumor development in mice. J Natl Cancer Inst. 78:149–154. 1987. View Article : Google Scholar : PubMed/NCBI
29	Teke K, Ozkan TA, Cebeci OO, Yilmaz H, Keles ME, Ozkan L, Dillioglugil MO, Yildiz DK and Dillioglugil O: Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats. Exp Anim. 66:191–198. 2017. View Article : Google Scholar : PubMed/NCBI
30	Kiziltan HŞ, Bayir AG, Yucesan G, Eris AH, İdin K, Karatoprak C, Aydin T, Akcakaya A and Mayadagli A: Medical ozone and radiotherapy in a peritoneal, Erlich-ascites, tumor-cell model. Altern Ther Health Med. 21:24–29. 2015.PubMed/NCBI
31	Schulz S, Haussler U, Mandic R, Heverhagen JT, Neubauer A, Dünne AA, Werner JA, Weihe E and Bette M: Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. Int J Cancer. 122:2360–2367. 2008. View Article : Google Scholar : PubMed/NCBI
32	Rossmann A, Mandic R, Heinis J, Höffken H, Küssner O, Kinscherf R, Weihe E and Bette M: Intraperitoneal oxidative stress in rabbits with papillomavirus-associated head and neck cancer induces tumoricidal immune response that is adoptively transferable. Clin Cancer Res. 20:4289–4301. 2014. View Article : Google Scholar : PubMed/NCBI
33	Bocci V: Does ozone really ‘cure’ cancer? Int J Cancer. 123:12222008. View Article : Google Scholar : PubMed/NCBI
34	Luongo M, Brigida AL, Mascolo L and Gaudino G: Possible therapeutic effects of ozone mixture on hypoxia in tumor development. Anticancer Res. 37:425–435. 2017. View Article : Google Scholar : PubMed/NCBI
35	Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P and Ellison DW: The 2016 World Health Organization Classification of tumors of the central nervous system: A summary. Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
36	Delic S, Lottmann N, Jetschke K, Reifenberger G and Riemenschneider MJ: Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion-associated candidate genes. Neuropathol Appl Neurobiol. 38:201–212. 2012. View Article : Google Scholar : PubMed/NCBI
37	Karnofsky DA: The bases for cancer chemotherapy. Stanford Med Bull. 6:257–269. 1948.PubMed/NCBI
38	Kewley RJ, Whitelaw ML and Chapman-Smith A: The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int J Biochem Cell Biol. 36:189–204. 2004. View Article : Google Scholar : PubMed/NCBI
39	Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 15:551–578. 1999. View Article : Google Scholar : PubMed/NCBI
40	Wenger RH, Stiehl DP and Camenisch G: Integration of oxygen signaling at the consensus HRE. Sci STKE. 2005:re122005.PubMed/NCBI
41	Semenza GL: HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol. 13:167–171. 2001. View Article : Google Scholar : PubMed/NCBI
42	Lee SJ, Song L, Yang MC, Mao CP, Yang B, Yang A, Jeang J, Peng S, Wu TC and Hung CF: Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation. Vaccine. 33:1549–1555. 2015. View Article : Google Scholar : PubMed/NCBI
43	Kucuksezer UC, Zekiroglu E, Kasapoglu P, Adin-Cinar S, Aktas-Cetin E and Deniz G: A stimulatory role of ozone exposure on human natural killer cells. Immunol Invest. 43:1–12. 2014. View Article : Google Scholar : PubMed/NCBI
44	Andreula CF, Simonetti L, De Santis F, Agati R, Ricci R and Leonardi M: Minimally invasive oxygen-ozone therapy for lumbar disk herniation. AJNR Am J Neuroradiol. 24:996–1000. 2003.PubMed/NCBI
45	Adeberg S, Bostel T, König L, Welzel T, Debus J and Combs SE: A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: A predictive factor for survival? Radiat Oncol. 9:952014. View Article : Google Scholar : PubMed/NCBI